As of 2025-05-22, the Intrinsic Value of Dhg Pharmaceutical Joint-Stock Co (DHG.VN) is 55.09 VND. This DHG.VN valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 106.70 VND, the upside of Dhg Pharmaceutical Joint-Stock Co is -48.40%.
The range of the Intrinsic Value is 42.43 - 78.90 VND
Based on its market price of 106.70 VND and our intrinsic valuation, Dhg Pharmaceutical Joint-Stock Co (DHG.VN) is overvalued by 48.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 42.43 - 78.90 | 55.09 | -48.4% |
| DCF (Growth 10y) | 45.11 - 78.45 | 56.87 | -46.7% |
| DCF (EBITDA 5y) | 56.99 - 97.43 | 72.98 | -31.6% |
| DCF (EBITDA 10y) | 54.36 - 92.53 | 69.24 | -35.1% |
| Fair Value | 29.57 - 29.57 | 29.57 | -72.29% |
| P/E | 71.31 - 111.15 | 92.07 | -13.7% |
| EV/EBITDA | 55.20 - 93.08 | 70.07 | -34.3% |
| EPV | 44.18 - 62.99 | 53.58 | -49.8% |
| DDM - Stable | 33.68 - 81.21 | 57.44 | -46.2% |
| DDM - Multi | 58.70 - 96.08 | 71.84 | -32.7% |
| Market Cap (mil) | 14,055,164.00 |
| Beta | 0.64 |
| Outstanding shares (mil) | 131,726.00 |
| Enterprise Value (mil) | 14,642,220.00 |
| Market risk premium | 9.50% |
| Cost of Equity | 11.42% |
| Cost of Debt | 4.25% |
| WACC | 11.09% |